Association Between Hypertension and New-Onset Non-Alcoholic Fatty Liver Disease in Chinese Non-Obese People: A Longitudinal Cohort Study

References

• Yu Y, Cai J, She Z, Li H. Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases. Adv Sci. 2019;6:1801585. doi:10.1002/advs.201801585
   Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–357. doi:10.1002/hep.29367
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. doi:10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–793. doi:10.1111/j.1440-1746.2007.05042.x
   PubMed Web of Science ®Google Scholar
• Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future. Liver Int. 2018;38(Suppl 1):47–51. doi:10.1111/liv.13643
   PubMed Web of Science ®Google Scholar
• Hyogo H, Chayama K, Yamagishi S. Nonalcoholic fatty liver disease and cardiovascular disease. Curr Pharm Des. 2014;20:2403–2411. doi:10.2174/13816128113199990476
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Tabibian JH, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. Plos Med. 2014;11:e1001680. doi:10.1371/journal.pmed.1001680
   PubMed Web of Science ®Google Scholar
• Zheng X, Cao C, He Y, Wang X, Wu J, Hu H. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. Lipids Health Dis. 2021;20:59. doi:10.1186/s12944-021-01485-x
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao G, Chen Z, She Z, Cai J, Li H. Nonalcoholic fatty liver disease. Hypertension. 2020;75:275–284. doi:10.1161/HYPERTENSIONAHA.119.13419
   PubMed Web of Science ®Google Scholar
• Negi CK, Babica P, Bajard L, Bienertova-Vasku J, Tarantino G. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. Metabolism. 2022;126:154925. doi:10.1016/j.metabol.2021.154925
   PubMed Web of Science ®Google Scholar
• Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263–2273. doi:10.1001/jama.2015.5370
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine. 2012;91:319–327. doi:10.1097/MD.0b013e3182779d49
   PubMed Web of Science ®Google Scholar
• Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862–873. doi:10.1016/j.jhep.2017.06.003
   PubMed Web of Science ®Google Scholar
• Vanwagner LB, Armstrong MJ. Lean NAFLD: a not so benign condition? Hepatol Commun. 2018;2:5–8. doi:10.1002/hep4.1143
   PubMed Web of Science ®Google Scholar
• Hagström H, Nasr P, Ekstedt M, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2:48–57. doi:10.1002/hep4.1124
   PubMed Web of Science ®Google Scholar
• Fukuda T, Hamaguchi M, Kojima T, et al. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. Liver Int. 2016;36:275–283. doi:10.1111/liv.12912
   PubMed Web of Science ®Google Scholar
• Yoshitaka H, Hamaguchi M, Kojima T, Fukuda T, Ohbora A, Fukui M. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: a post hoc analysis of a cohort study. Medicine. 2017;96:e6712. doi:10.1097/MD.0000000000006712
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71:e13–e115. doi:10.1161/HYP.0000000000000065
   PubMed Web of Science ®Google Scholar
• Vasunta RL, Kesäniemi YA, Ylitalo AS, Ukkola OH. High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults. J Hypertens. 2012;30:2015–2019. doi:10.1097/HJH.0b013e3283576faf
   PubMed Web of Science ®Google Scholar
• Xu S, Chen L, Hong D, Yang L, Li X, Wang X. Mean arterial pressure is related to incident nonalcoholic fatty liver disease among the nonobese female with normal low-density lipoprotein cholesterol levels: a large cohort study in China. Gastronet Res Pract. 2020;2020:1–9. doi:10.1155/2020/2549486
   Web of Science ®Google Scholar
• Wu SJ, Zou H, Zhu GQ, et al. Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease. Medicine. 2015;94:e842. doi:10.1097/MD.0000000000000842
   PubMed Web of Science ®Google Scholar
• Qian LY, Tu JF, Ding YH, et al. Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: normal is not the new normal. Medicine. 2016;95:e4293. doi:10.1097/MD.0000000000004293
   PubMed Web of Science ®Google Scholar
• Wu S, Zou H, Zhu G, et al. Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease. Medicine. 2015;94:e842.
   PubMed Web of Science ®Google Scholar
• Aneni EC, Oni ET, Martin SS, et al. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk. J Hypertens. 2015;33:1207–1214. doi:10.1097/HJH.0000000000000532
   PubMed Web of Science ®Google Scholar
• Li G, Peng Y, Chen Z, Li H, Liu D, Ye X. Bidirectional association between hypertension and NAFLD: a systematic review and meta-analysis of observational studies. Int J Endocrinol. 2022;2022:1–10.
   Web of Science ®Google Scholar
• Tsuneto A, Hida A, Sera N, et al. Fatty liver incidence and predictive variables. Hypertens Res. 2010;33:638–643. doi:10.1038/hr.2010.45
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang C, Zhang Y, et al. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study. Atherosclerosis. 2015;240:144–148. doi:10.1016/j.atherosclerosis.2015.02.049
   PubMed Web of Science ®Google Scholar
• Liu P, Tang Y, Guo X, et al. Bidirectional association between nonalcoholic fatty liver disease and hypertension from the Dongfeng-Tongji cohort study. J Am Soc Hypertens. 2018;12:660–670. doi:10.1016/j.jash.2018.06.013
   PubMed Web of Science ®Google Scholar
• Kirovski G, Schacherer D, Wobser H, et al. Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. Int J Clin Exp Med. 2010;3:202–210.
   PubMed Web of Science ®Google Scholar
• Huang Q, Yu H, Zhong X, Tian Y, Cui Z, Quan Z. Association between hypertension and nonalcoholic fatty liver disease: a cross-sectional and meta-analysis study. J Hum Hypertens. 2022. doi:10.1038/s41371-022-00686-w
   Web of Science ®Google Scholar
• Yin JM, Li Z, Jiang LY. Case-control study on the risk factors of nonalcoholic fatty liver disease based on physical examination people in hospital. Chin J Prev Control Chronic Dis. 2011;20:154.
   Google Scholar
• Siu JM, McCarty JC, Gadkaree S, et al. Association of vessel-sealant devices vs conventional hemostasis with postoperative neck hematoma after thyroid operations. Jama Surg. 2019;154:e193146. doi:10.1001/jamasurg.2019.3146
   PubMed Web of Science ®Google Scholar
• Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med. 2002;137:693–695. doi:10.7326/0003-4819-137-8-200210150-00015
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. Constructing a Control Group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–38.
   Web of Science ®Google Scholar
• Thomas RN, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996;52:249–264. doi:10.2307/2533160
   PubMed Web of Science ®Google Scholar
• D’Agostino RJ. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281. doi:10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   PubMed Web of Science ®Google Scholar
• Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382:2411–2418. doi:10.1056/NEJMoa2012410
   PubMed Web of Science ®Google Scholar
• Hirano K, Imbens GW, Ridder G. Efficient estimation of average treatment effects using the estimated propensity score. Econometrica. 2003;71:1161–1189. doi:10.1111/1468-0262.00442
   Web of Science ®Google Scholar
• Hirano K, Imbens GW. Estimation of causal effects using propensity score weighting: an application to data on right heart catheterization. Health Serv Outcomes Res Methodol. 2001;2:259–278. doi:10.1023/A:1020371312283
   Google Scholar
• Wu Y, Hu H, Cai J, et al. Association of hypertension and incident diabetes in Chinese adults: a retrospective cohort study using propensity-score matching. BMC Endocr Disord. 2021;21:87. doi:10.1186/s12902-021-00747-0
   PubMed Web of Science ®Google Scholar
• Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550–560. doi:10.1097/00001648-200009000-00011
   PubMed Web of Science ®Google Scholar
• Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology. 2003;14:680–686. doi:10.1097/01.EDE.0000081989.82616.7d
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158:280–287. doi:10.1093/aje/kwg115
   PubMed Web of Science ®Google Scholar
• Harrell FJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Harrell FJ, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3:143–152. doi:10.1002/sim.4780030207
   PubMed Web of Science ®Google Scholar
• Sun D, Wu S, Liu W, et al. Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study. BMJ Open. 2016;6:e13781. doi:10.1136/bmjopen-2016-013781
   PubMed Web of Science ®Google Scholar
• Wu SJ, Zhu GQ, Ye BZ, et al. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. Medicine. 2015;94:e802. doi:10.1097/MD.0000000000000802
   PubMed Web of Science ®Google Scholar
• Zeng MD, Li YM, Chen CW, et al. Guidelines for the diagnosis and treatment of alcoholic liver disease. J Dig Dis. 2008;9:113–116. doi:10.1111/j.1751-2980.2008.00332.x
   PubMed Web of Science ®Google Scholar
• Gao X, Fan JG. Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. J Diabetes. 2013;5:406–415. doi:10.1111/1753-0407.12056
   PubMed Web of Science ®Google Scholar
• Jones NR, McCormack T, Constanti M, McManus RJ. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020;70:90–91. doi:10.3399/bjgp20X708053
   PubMed Web of Science ®Google Scholar
• Wang JG, Chia YC, Chen CH, et al. What is new in the 2018 Chinese hypertension guideline and the implication for the management of hypertension in Asia? J Clin Hypertens. 2020;22:363–368. doi:10.1111/jch.13803
   Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Rev Esp Cardiol. 2019;72:160. doi:10.1016/j.rec.2018.12.004
   PubMed Web of Science ®Google Scholar
• Wu Y, Hu H, Cai J, et al. A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults. Sci Rep. 2020;10:21716. doi:10.1038/s41598-020-78716-1
   PubMed Web of Science ®Google Scholar
• Groenwold RH, White IR, Donders AR, Carpenter JR, Altman DG, Moons KG. Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ. 2012;184:1265–1269. doi:10.1503/cmaj.110977
   PubMed Web of Science ®Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399. doi:10.1002/sim.4067
   PubMed Web of Science ®Google Scholar
• Ahmed A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27:1431–1439. doi:10.1093/eurheartj/ehi890
   PubMed Web of Science ®Google Scholar
• Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54:387–398. doi:10.1016/S0895-4356(00)00321-8
   PubMed Web of Science ®Google Scholar
• Austin P. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat. 2009;1228–1234. doi:10.1080/03610910902859574
   Google Scholar
• Navale SM, Szubski CR, Klika AK, Schiltz NK, Desai PP, Barsoum WK. The impact of solid organ transplant history on inpatient complications, mortality, length of stay, and cost for primary total hip arthroplasty admissions in the United States. J Arthroplasty. 2017;32:1107–1116. doi:10.1016/j.arth.2016.10.017
   PubMed Web of Science ®Google Scholar
• Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561–570. doi:10.1097/00001648-200009000-00012
   PubMed Web of Science ®Google Scholar
• Abadie A, Imbens GW. Bias-corrected matching estimators for average treatment effects. J Bus Econ Stat. 2011;29:1–11. doi:10.1198/jbes.2009.07333
   Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495–1499. doi:10.1016/j.ijsu.2014.07.013
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Plos Med. 2007;4:e297. doi:10.1371/journal.pmed.0040297
   PubMed Web of Science ®Google Scholar
• Haneuse S, VanderWeele TJ, Arterburn D. Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321:602–603. doi:10.1001/jama.2018.21554
   PubMed Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–968. doi:10.1001/jama.2013.184182
   PubMed Web of Science ®Google Scholar
• Fallo F, Dalla PA, Sonino N, et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis. 2009;19:646–653. doi:10.1016/j.numecd.2008.12.007
   PubMed Web of Science ®Google Scholar
• Tarantino G, Balsano C, Santini SJ, et al. It is high time physicians thought of natural products for alleviating NAFLD. Is there sufficient evidence to use them? Int J Mol Sci. 2021;22:13424. doi:10.3390/ijms222413424
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The bias due to incomplete matching. Biometrics. 1985;41:103–116. doi:10.2307/2530647
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension. 1997;30:1144–1149. doi:10.1161/01.HYP.30.5.1144
   PubMed Web of Science ®Google Scholar
• Mancia G, Facchetti R, Bombelli M, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension. 2005;45:1072–1077. doi:10.1161/01.HYP.0000165672.69176.ed
   PubMed Web of Science ®Google Scholar
• Zhao YC, Zhao GJ, Chen Z, She ZG, Cai J, Li H. Nonalcoholic fatty liver disease: an emerging driver of hypertension. Hypertension. 2020;75:275–284.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Hoffman BB. A role for insulin in the aetiology and course of hypertension? Lancet. 1987;2:435–437. doi:10.1016/S0140-6736(87)90968-8
   PubMed Web of Science ®Google Scholar
• Donati G, Stagni B, Piscaglia F, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 2004;53:1020–1023. doi:10.1136/gut.2003.027086
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350–357. doi:10.1056/NEJM198708063170605
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48:634–642. doi:10.1007/s00125-005-1682-x
   PubMed Web of Science ®Google Scholar
• Manosroi W, Williams GH. Genetics of human primary hypertension: focus on hormonal mechanisms. Endocr Rev. 2019;40:825–856. doi:10.1210/er.2018-00071
   PubMed Web of Science ®Google Scholar
• Scharfstein DO, Robins R, Robins JM. Adjusting for nonignorable drop-out using semiparametric nonresponse models. J Am Stat Assoc. 1999;94:1096–1120. doi:10.1080/01621459.1999.10473862
   Web of Science ®Google Scholar